Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis

References

• Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56: 772–81
   PubMed Web of Science ®Google Scholar
• Sobala G, Crabtree J, Dixon M, Schorah C, Taylor J, Rathbone B, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991; 32: 1415–8
   PubMed Web of Science ®Google Scholar
• Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect. 1997; 119: 29–34
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2: 161–74
   PubMed Web of Science ®Google Scholar
• Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006; 38: 306–21
   PubMed Web of Science ®Google Scholar
• McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol. 2004; 172: 2586–94
   PubMed Web of Science ®Google Scholar
• Elkington PTG, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol. 2005; 142: 12–20
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002; 3: 207–14
   PubMed Web of Science ®Google Scholar
• Hartog CM, Wermelt JA, Sommerfeld CO, Eichler W, Dalhoff K, Braun J. Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia. Am J Respir Crit Care Med. 2003; 167: 593–8
   PubMed Web of Science ®Google Scholar
• Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002; 115: 3719–27
   PubMed Web of Science ®Google Scholar
• Bodger K, Ahmed S, Pazmany L, Pritchard DM, Michael A, Khan AL, et al. Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection. J Clin Pathol. 2008; 61: 72–8
   Google Scholar
• Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989; 320: 365–76
   PubMed Web of Science ®Google Scholar
• Geraghty P, Rogan MP, Greene CM, Boxio RMM, Poiriert T, O'Mahony M, et al. Neutrophil elastase up-regulates cathepsin B and matrix metalloproteinase-2 expression. J Immunol. 2007; 178: 5871–8
   PubMed Web of Science ®Google Scholar
• Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, et al. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue. J Biol Chem. 2007; 282: 31826–34
   PubMed Web of Science ®Google Scholar
• Hellmig S, Ott S, Rosenstiel P, Fölsch UR, Hampe J, Schreiber S. Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. pylori infection. Am J Gastroenterol. 2006; 101: 29–35
   PubMed Web of Science ®Google Scholar
• Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol. 2006; 59: 618–23
   PubMed Web of Science ®Google Scholar
• Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, et al. Expression of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric cancer. Anticancer Res. 2006; 26: 3579–83
   PubMed Web of Science ®Google Scholar
• Bergin PJ, Edebo A, Wen S, Johnsson E, Andersson J, Lönroth H, et al. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter. 2004; 9: 201–10
   PubMed Web of Science ®Google Scholar
• Koyama S. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 2004; 39: 1046–53
   PubMed Web of Science ®Google Scholar
• Yanagisawa N, Geironson L, Al-Soud WA, Ljungh Å. Expression of matrix metalloproteinase-2, -7, -9 on human colon, liver and bile duct cell lines by enteric and gastric Helicobacter species. FEMS Immunol Med Microbiol. 2004; 44: 197–204
   Google Scholar
• Kundu P, Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem. 2006; 281: 34651–62
   PubMed Web of Science ®Google Scholar
• Oliveira MJ, Costa AC, Costa AM, Henriques L, Suriano G, Atherton J, et al. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J Biol Chem. 2006; 281: 34888–96
   PubMedGoogle Scholar
• Bebb JR, Letley DP, Thomas RJ, Aviles F, Collins HM, Watson SA, et al. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut. 2003; 52: 1408–13
   PubMed Web of Science ®Google Scholar
• Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 2003; 125: 1125–36
   PubMed Web of Science ®Google Scholar
• Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor (B. Gastroenterology. 2003; 124: 983–92
   PubMed Web of Science ®Google Scholar
• Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, et al. Helicobacter pylori promote gastric cancer cell invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol. 2005; 11: 3197–203
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996; 20: 1161–81
   PubMed Web of Science ®Google Scholar
• Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem. 1989; 27: 351–9
   PubMedGoogle Scholar
• Lauhio A, Konttinen YT, Tschesche H, Nordstrom D, Salo T, Lahdevirta J, et al. Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob Agents Chemother. 1994; 38: 400–2
   PubMed Web of Science ®Google Scholar
• Bergin PJ, Wen S, Pan-Hammarström Q, Quiding-Järbrink M. Secretion of matrix metalloproteinase-9 by macrophages, in vitro, in response to Helicobacter pylori. FEMS Immunol Med Microbiol. 2005; 45: 159–69
   Google Scholar
• Yokoyama T, Otani Y, Kurihara N, Sakurai Y, Kameyama K, Suzuki H, et al. Matrix metalloproteinase expression in cultured human gastric wall fibroplasts—interactions with Helicobacter pylori isolated from patients with ulcers. Aliment Pharmacol Ther. 2000; 14: 193–8
   Google Scholar
• McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 2000; 289: 1202–6
   PubMed Web of Science ®Google Scholar
• Dozier S, Escobar GP, Lindsey ML. Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13. Med Chem. 2006; 2: 523–6
   Google Scholar
• Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a meta analysis. Am Heart J. 2006; 151: 1215–22
   PubMed Web of Science ®Google Scholar
• Danese S, Papa A, Ricci R, Maggiano N. Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. Gastroenterology. 2004; 126: 369–71
   Google Scholar
• Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998; 32: 368–72
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003; 107: 1579–85
   PubMed Web of Science ®Google Scholar
• Lint VP, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006; 17: 217–23
   Google Scholar
• Tuomainen AM, Nyyssönen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscl Tromb Vasc Biol 2007; 27: 2722–8
   PubMed Web of Science ®Google Scholar
• Kubben FJGM, Sier CFM, Meijer MJW, van den Berg M, van der Reijden JJ, Griffioen G, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer. 2006; 95: 744–51
   PubMedGoogle Scholar
• Torii A, Kodera Y, Uesaka K, Hirai T, Yasui K, Morimoto T, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg. 1997; 84: 133–6
   PubMedGoogle Scholar